Rotavirus A Outer Capsid Glycoprotein VP7 (Serotype G9) (VP7 (G9))

Rotavirus A Outer Capsid Glycoprotein VP7 (Serotype G9) is a major structural protein that forms the smooth outer surface of the rotavirus virion. It is a calcium-binding protein essential for the integrity of the outer shell and plays a pivotal role in the early stages of the viral life cycle, including cell attachment and penetration (UniProt: P04502). VP7 defines the G-serotype of the virus and is a primary target for the host's neutralizing antibody response, making it a critical component in vaccine design (PubMed: 11831705). The G9 serotype, once considered rare, has emerged as one of the most prevalent strains worldwide, contributing significantly to the global burden of severe pediatric gastroenteritis (PubMed: 15529253). Current live-attenuated vaccines, such as RotaTeq and Rotarix, aim to elicit protective immunity against common serotypes including G9 to prevent rotavirus-induced dehydration and mortality (CDC: Rotavirus Vaccination). Therapeutic strategies focusing on VP7 involve the development of monoclonal antibodies and next-generation vaccines to address the diversity of circulating strains (PubMed: 28438887). Understanding the structural variations in the G9 serotype is essential for monitoring vaccine efficacy and the potential for antigenic escape (PubMed: 22438298).

Other names

VP7Outer capsid glycoprotein VP7G9 proteinGlycoprotein 7VP7 serotype G9Major neutralization antigen VP7

Induction of neutralizing antibodies (primarily IgA) that bind to the VP7 protein on the viral outer capsid, thereby preventing viral attachment to host enterocytes and inhibiting the calcium-dependent uncoating process required for viral entry into the cytoplasm.